nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—Cardiovascular disorder—Risedronate—Paget's disease of bone	0.0183	0.0183	CcSEcCtD
Neostigmine—Arthralgia—Tiludronate—Paget's disease of bone	0.0182	0.0182	CcSEcCtD
Neostigmine—Osteoarthritis—Etidronic acid—Paget's disease of bone	0.017	0.017	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.0159	0.0159	CcSEcCtD
Neostigmine—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.0143	0.0143	CcSEcCtD
Neostigmine—Abdominal pain—Tiludronate—Paget's disease of bone	0.0138	0.0138	CcSEcCtD
Neostigmine—Cramp muscle—Alendronate—Paget's disease of bone	0.0131	0.0131	CcSEcCtD
Neostigmine—Asthenia—Tiludronate—Paget's disease of bone	0.0125	0.0125	CcSEcCtD
Neostigmine—Diarrhoea—Tiludronate—Paget's disease of bone	0.012	0.012	CcSEcCtD
Neostigmine—Osteoarthritis—Risedronate—Paget's disease of bone	0.0116	0.0116	CcSEcCtD
Neostigmine—Dizziness—Tiludronate—Paget's disease of bone	0.0116	0.0116	CcSEcCtD
Neostigmine—Osteoarthritis—Pamidronate—Paget's disease of bone	0.0111	0.0111	CcSEcCtD
Neostigmine—Headache—Tiludronate—Paget's disease of bone	0.0109	0.0109	CcSEcCtD
Neostigmine—Nausea—Tiludronate—Paget's disease of bone	0.0104	0.0104	CcSEcCtD
Neostigmine—Osteoarthritis—Zoledronate—Paget's disease of bone	0.0101	0.0101	CcSEcCtD
Neostigmine—Flatulence—Etidronic acid—Paget's disease of bone	0.0101	0.0101	CcSEcCtD
Neostigmine—Cramp muscle—Pamidronate—Paget's disease of bone	0.00997	0.00997	CcSEcCtD
Neostigmine—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00986	0.00986	CcSEcCtD
Neostigmine—Bronchospasm—Pamidronate—Paget's disease of bone	0.00941	0.00941	CcSEcCtD
Neostigmine—Sweating increased—Pamidronate—Paget's disease of bone	0.00932	0.00932	CcSEcCtD
Neostigmine—Cramp muscle—Zoledronate—Paget's disease of bone	0.0091	0.0091	CcSEcCtD
Neostigmine—Arthralgia—Etidronic acid—Paget's disease of bone	0.00873	0.00873	CcSEcCtD
Neostigmine—Flatulence—Alendronate—Paget's disease of bone	0.00861	0.00861	CcSEcCtD
Neostigmine—Bronchospasm—Zoledronate—Paget's disease of bone	0.00859	0.00859	CcSEcCtD
Neostigmine—Sweating increased—Zoledronate—Paget's disease of bone	0.00851	0.00851	CcSEcCtD
Neostigmine—Muscle spasms—Alendronate—Paget's disease of bone	0.0084	0.0084	CcSEcCtD
Neostigmine—Pollakiuria—Zoledronate—Paget's disease of bone	0.00807	0.00807	CcSEcCtD
Neostigmine—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00795	0.00795	CcSEcCtD
Neostigmine—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00791	0.00791	CcSEcCtD
Neostigmine—Urethral disorder—Risedronate—Paget's disease of bone	0.00789	0.00789	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00762	0.00762	CcSEcCtD
Neostigmine—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00756	0.00756	CcSEcCtD
Neostigmine—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00752	0.00752	CcSEcCtD
Neostigmine—Urethral disorder—Pamidronate—Paget's disease of bone	0.0075	0.0075	CcSEcCtD
Neostigmine—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00726	0.00726	CcSEcCtD
Neostigmine—Arrhythmia—Risedronate—Paget's disease of bone	0.00719	0.00719	CcSEcCtD
Neostigmine—Bradycardia—Zoledronate—Paget's disease of bone	0.00712	0.00712	CcSEcCtD
Neostigmine—Flushing—Pamidronate—Paget's disease of bone	0.00711	0.00711	CcSEcCtD
Neostigmine—Mental disorder—Risedronate—Paget's disease of bone	0.00706	0.00706	CcSEcCtD
Neostigmine—Flatulence—Risedronate—Paget's disease of bone	0.00691	0.00691	CcSEcCtD
Neostigmine—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00691	0.00691	CcSEcCtD
Neostigmine—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.0069	0.0069	CcSEcCtD
Neostigmine—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00687	0.00687	CcSEcCtD
Neostigmine—Urethral disorder—Zoledronate—Paget's disease of bone	0.00686	0.00686	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00684	0.00684	CcSEcCtD
Neostigmine—Muscle spasms—Risedronate—Paget's disease of bone	0.00674	0.00674	CcSEcCtD
Neostigmine—Urticaria—Etidronic acid—Paget's disease of bone	0.00665	0.00665	CcSEcCtD
Neostigmine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00662	0.00662	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.0065	0.0065	CcSEcCtD
Neostigmine—Flushing—Zoledronate—Paget's disease of bone	0.00649	0.00649	CcSEcCtD
Neostigmine—Muscle spasms—Pamidronate—Paget's disease of bone	0.00641	0.00641	CcSEcCtD
Neostigmine—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.0063	0.0063	CcSEcCtD
Neostigmine—Syncope—Risedronate—Paget's disease of bone	0.00629	0.00629	CcSEcCtD
Neostigmine—Arrhythmia—Zoledronate—Paget's disease of bone	0.00625	0.00625	CcSEcCtD
Neostigmine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00617	0.00617	CcSEcCtD
Neostigmine—Loss of consciousness—Risedronate—Paget's disease of bone	0.00616	0.00616	CcSEcCtD
Neostigmine—Mental disorder—Zoledronate—Paget's disease of bone	0.00613	0.00613	CcSEcCtD
Neostigmine—Agitation—Pamidronate—Paget's disease of bone	0.00612	0.00612	CcSEcCtD
Neostigmine—Syncope—Pamidronate—Paget's disease of bone	0.00598	0.00598	CcSEcCtD
Neostigmine—Arthralgia—Risedronate—Paget's disease of bone	0.00597	0.00597	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00593	0.00593	CcSEcCtD
Neostigmine—Pruritus—Etidronic acid—Paget's disease of bone	0.00592	0.00592	CcSEcCtD
Neostigmine—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00586	0.00586	CcSEcCtD
Neostigmine—Muscle spasms—Zoledronate—Paget's disease of bone	0.00585	0.00585	CcSEcCtD
Neostigmine—Dry mouth—Risedronate—Paget's disease of bone	0.00584	0.00584	CcSEcCtD
Neostigmine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00583	0.00583	CcSEcCtD
Neostigmine—Convulsion—Pamidronate—Paget's disease of bone	0.00577	0.00577	CcSEcCtD
Neostigmine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00573	0.00573	CcSEcCtD
Neostigmine—Arthralgia—Pamidronate—Paget's disease of bone	0.00567	0.00567	CcSEcCtD
Neostigmine—Urticaria—Alendronate—Paget's disease of bone	0.00567	0.00567	CcSEcCtD
Neostigmine—Abdominal pain—Alendronate—Paget's disease of bone	0.00564	0.00564	CcSEcCtD
Neostigmine—Shock—Risedronate—Paget's disease of bone	0.00563	0.00563	CcSEcCtD
Neostigmine—Nervous system disorder—Risedronate—Paget's disease of bone	0.00561	0.00561	CcSEcCtD
Neostigmine—Agitation—Zoledronate—Paget's disease of bone	0.00559	0.00559	CcSEcCtD
Neostigmine—Skin disorder—Risedronate—Paget's disease of bone	0.00556	0.00556	CcSEcCtD
Neostigmine—Syncope—Zoledronate—Paget's disease of bone	0.00546	0.00546	CcSEcCtD
Neostigmine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00544	0.00544	CcSEcCtD
Neostigmine—Shock—Pamidronate—Paget's disease of bone	0.00535	0.00535	CcSEcCtD
Neostigmine—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00535	0.00535	CcSEcCtD
Neostigmine—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00533	0.00533	CcSEcCtD
Neostigmine—Vomiting—Etidronic acid—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Neostigmine—Tachycardia—Pamidronate—Paget's disease of bone	0.00531	0.00531	CcSEcCtD
Neostigmine—Rash—Etidronic acid—Paget's disease of bone	0.00528	0.00528	CcSEcCtD
Neostigmine—Convulsion—Zoledronate—Paget's disease of bone	0.00527	0.00527	CcSEcCtD
Neostigmine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00527	0.00527	CcSEcCtD
Neostigmine—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00526	0.00526	CcSEcCtD
Neostigmine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00525	0.00525	CcSEcCtD
Neostigmine—Headache—Etidronic acid—Paget's disease of bone	0.00524	0.00524	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00521	0.00521	CcSEcCtD
Neostigmine—Arthralgia—Zoledronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Neostigmine—Insomnia—Risedronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00515	0.00515	CcSEcCtD
Neostigmine—Asthenia—Alendronate—Paget's disease of bone	0.00512	0.00512	CcSEcCtD
Neostigmine—Dyspnoea—Risedronate—Paget's disease of bone	0.0051	0.0051	CcSEcCtD
Neostigmine—Hypotension—Pamidronate—Paget's disease of bone	0.00508	0.00508	CcSEcCtD
Neostigmine—Dry mouth—Zoledronate—Paget's disease of bone	0.00507	0.00507	CcSEcCtD
Neostigmine—Pruritus—Alendronate—Paget's disease of bone	0.00505	0.00505	CcSEcCtD
Neostigmine—Nausea—Etidronic acid—Paget's disease of bone	0.00497	0.00497	CcSEcCtD
Neostigmine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00497	0.00497	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00496	0.00496	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00494	0.00494	CcSEcCtD
Neostigmine—Insomnia—Pamidronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Neostigmine—Shock—Zoledronate—Paget's disease of bone	0.00489	0.00489	CcSEcCtD
Neostigmine—Diarrhoea—Alendronate—Paget's disease of bone	0.00488	0.00488	CcSEcCtD
Neostigmine—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00487	0.00487	CcSEcCtD
Neostigmine—Dyspnoea—Pamidronate—Paget's disease of bone	0.00485	0.00485	CcSEcCtD
Neostigmine—Tachycardia—Zoledronate—Paget's disease of bone	0.00485	0.00485	CcSEcCtD
Neostigmine—Somnolence—Pamidronate—Paget's disease of bone	0.00484	0.00484	CcSEcCtD
Neostigmine—Skin disorder—Zoledronate—Paget's disease of bone	0.00483	0.00483	CcSEcCtD
Neostigmine—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.0048	0.0048	CcSEcCtD
Neostigmine—Dizziness—Alendronate—Paget's disease of bone	0.00472	0.00472	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.0047	0.0047	CcSEcCtD
Neostigmine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Neostigmine—Hypotension—Zoledronate—Paget's disease of bone	0.00464	0.00464	CcSEcCtD
Neostigmine—Urticaria—Risedronate—Paget's disease of bone	0.00455	0.00455	CcSEcCtD
Neostigmine—Vomiting—Alendronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Neostigmine—Abdominal pain—Risedronate—Paget's disease of bone	0.00452	0.00452	CcSEcCtD
Neostigmine—Rash—Alendronate—Paget's disease of bone	0.0045	0.0045	CcSEcCtD
Neostigmine—Insomnia—Zoledronate—Paget's disease of bone	0.00449	0.00449	CcSEcCtD
Neostigmine—Dermatitis—Alendronate—Paget's disease of bone	0.00449	0.00449	CcSEcCtD
Neostigmine—Headache—Alendronate—Paget's disease of bone	0.00447	0.00447	CcSEcCtD
Neostigmine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00445	0.00445	CcSEcCtD
Neostigmine—Dyspnoea—Zoledronate—Paget's disease of bone	0.00443	0.00443	CcSEcCtD
Neostigmine—Somnolence—Zoledronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Neostigmine—Abdominal pain—Pamidronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00429	0.00429	CcSEcCtD
Neostigmine—Nausea—Alendronate—Paget's disease of bone	0.00424	0.00424	CcSEcCtD
Neostigmine—Hypersensitivity—Risedronate—Paget's disease of bone	0.00422	0.00422	CcSEcCtD
Neostigmine—Asthenia—Risedronate—Paget's disease of bone	0.00411	0.00411	CcSEcCtD
Neostigmine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Neostigmine—Pruritus—Risedronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Neostigmine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00401	0.00401	CcSEcCtD
Neostigmine—Urticaria—Zoledronate—Paget's disease of bone	0.00395	0.00395	CcSEcCtD
Neostigmine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Neostigmine—Diarrhoea—Risedronate—Paget's disease of bone	0.00391	0.00391	CcSEcCtD
Neostigmine—Asthenia—Pamidronate—Paget's disease of bone	0.0039	0.0039	CcSEcCtD
Neostigmine—Pruritus—Pamidronate—Paget's disease of bone	0.00385	0.00385	CcSEcCtD
Neostigmine—Dizziness—Risedronate—Paget's disease of bone	0.00378	0.00378	CcSEcCtD
Neostigmine—Diarrhoea—Pamidronate—Paget's disease of bone	0.00372	0.00372	CcSEcCtD
Neostigmine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00366	0.00366	CcSEcCtD
Neostigmine—Vomiting—Risedronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Neostigmine—Rash—Risedronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Neostigmine—Dermatitis—Risedronate—Paget's disease of bone	0.0036	0.0036	CcSEcCtD
Neostigmine—Dizziness—Pamidronate—Paget's disease of bone	0.0036	0.0036	CcSEcCtD
Neostigmine—Headache—Risedronate—Paget's disease of bone	0.00358	0.00358	CcSEcCtD
Neostigmine—Asthenia—Zoledronate—Paget's disease of bone	0.00356	0.00356	CcSEcCtD
Neostigmine—Pruritus—Zoledronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Neostigmine—Vomiting—Pamidronate—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Neostigmine—Rash—Pamidronate—Paget's disease of bone	0.00343	0.00343	CcSEcCtD
Neostigmine—Dermatitis—Pamidronate—Paget's disease of bone	0.00343	0.00343	CcSEcCtD
Neostigmine—Headache—Pamidronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Neostigmine—Diarrhoea—Zoledronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Neostigmine—Nausea—Risedronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Neostigmine—Dizziness—Zoledronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Neostigmine—Nausea—Pamidronate—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Neostigmine—Vomiting—Zoledronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
Neostigmine—Rash—Zoledronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Neostigmine—Dermatitis—Zoledronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Neostigmine—Headache—Zoledronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Neostigmine—Nausea—Zoledronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
